Spironolactone-induced agranulocytosis.
Agranulocytosis associated with spironolactone administration is described in a 57-year-old man. Four days after initiation of spironolactone, leukocyte counts decreased from 8.2 to 2.3 X 10(9)/L with 6% neutrophils. Spironolactone, domperidone, and prochlorperazine were discontinued. Domperidone and prochlorperazine were reintroduced and there was concomitant improvement of the leukocyte and neutrophil counts. Substitution of triamterene for spironolactone was not associated with recurrent leukopenia. The potential association of spironolactone with granulocytopenia warrants increased awareness of this rare but serious adverse drug reaction.
Jivraj
K T
KT
Department of Adult Intensive Care, Royal Alexandra Hospital, Edmonton, Alberta, Canada.
Noseworthy
T W
TW
Friesen
E G
EG
Shustack
A S
AS
Konopad
E M
EM
Johnston
R G
RG
D000380:Agranulocytosis / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D013148:Spironolactone / Q000009:adverse effects*
D013148:Spironolactone